Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.32 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.32 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10316754 | 0.89 | POLB (0.41) | POLBALDH1A1TDP1MCL1SLC2A1 | |
| SCHEMBL10753814 | 0.79 | POLB (0.32) | POLBALDH1A1TDP1 | |
| SCHEMBL30536564 | 0.75 | ALDH1A1 (0.39) | POLBALDH1A1TDP1MCL1 | |
| SCHEMBL14870490 | 0.74 | POLB (0.43) | POLBALDH1A1TDP1MCL1CYP1A2 | |
| SCHEMBL3240790 | 0.74 | POLB (0.36) | POLBALDH1A1TDP1MCL1 | |
| SCHEMBL21328389 | 0.73 | POLB (0.32) | POLBALDH1A1TDP1 | |
| SCHEMBL14879721 | 0.72 | ALDH1A1 (0.40) | POLBALDH1A1TDP1MCL1GAA | |
| SCHEMBL18834394 | 0.71 | ALDH1A1 (0.46) | POLBALDH1A1TDP1MCL1SLC2A1 | |
| SCHEMBL31675176 | 0.69 | POLB (0.56) | POLBALDH1A1TDP1MCL1SLC2A1 | |
| SCHEMBL869519 | 0.69 | POLB (0.56) | POLBALDH1A1TDP1MCL1SLC2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4338761-A1 | PERFUMING COMPOSITIONS | Firmenich SA (CH) | 2024-03-20 | — | — | EP | disclosed |
| US-11744785-B2 | Use of volatile compositions to limit or eliminate the perception of malodor | FIRMENICH SA (CH) | 2023-09-05 | — | — | US | disclosed |
| US-20230233425-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | FIRMENICH SA (CH) | 2023-07-27 | — | — | US | disclosed |
| US-20200345601-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | FIRMENICH SA (CH) | 2020-11-05 | — | — | US | disclosed |
| US-20190241832-A1 | Improvements in or Relating to Organic Compounds | GIVAUDAN SA (CH) | 2019-08-08 | — | — | US | disclosed |
| EP-3310893-A1 | IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS | Givaudan SA (CH) | 2018-04-25 | — | — | EP | disclosed |
| WO-2016207179-A1 | IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2016-12-29 | — | — | WO | disclosed |
| US-8772348-B2 | Materials and methods for pest control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2014-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11744785-B2 | Use of volatile compositions to limit or eliminate the perception of malodor | TAS2R8, TRPA1, TAS2R10 | POLB 1959/4885ALDH1A1 831/4885TDP1 4384/4885 |
| US-20200345601-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | TAS2R8, TRPA1, TAS2R10 | POLB 1959/4885ALDH1A1 831/4885TDP1 4384/4885 |
| US-20230233425-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | TAS2R8, TRPA1, TAS2R10 | POLB 1959/4885ALDH1A1 831/4885TDP1 4384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.